A human antibody, cloned from a patient with heparin-induced thrombocytopenia, that binds heparin/platelet factor 4 complexes.

被引：0
|
作者：
Dessain, SK
Rybinski, KE
Adekar, SP
Rauova, L
Sachais, BS
McKenzie, SE
Reilly, MP
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
58
引用
收藏
页码：21A / 22A
页数：2
相关论文
共 50 条
  • [41] Antibodies to Heparin-Platelet Factor 4 Complex: Pathogenesis, Epidemiology, and Management of Heparin-Induced Thrombocytopenia in Hemodialysis
    Davenport, Andrew
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (02) : 361 - 374
  • [42] Laboratory diagnosis of heparin-induced thrombocytopenia type II after clearance of platelet factor 4/heparin complex
    Harenberg, J
    Wang, LC
    Hoffmann, U
    Huhle, G
    Feuring, M
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (06): : 408 - 413
  • [43] Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patient with heparin-induced antibodies
    Hewitt, RL
    Akers, DL
    Leissinger, CA
    Gill, JI
    Aster, RH
    JOURNAL OF VASCULAR SURGERY, 1998, 28 (03) : 561 - 565
  • [44] Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia
    Lindhoff-Last, E
    Gerdsen, F
    Ackermann, H
    Bauersachs, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) : 886 - 890
  • [45] Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis
    Look, KA
    Sahud, M
    Flaherty, S
    Zehnder, JL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 108 (01) : 78 - 82
  • [46] CABG without using heparin in a patient with heparin-induced thrombocytopenia
    Altop, S
    Yildirim, T
    Selimoglu, Ö
    Ömeroglu, SN
    Ogus, T
    JOURNAL OF CARDIAC SURGERY, 2006, 21 (03) : 298 - 300
  • [47] The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin platelet factor 4 complexes
    Gruel, Y
    Pouplard, C
    Lasne, D
    Magdelaine-Beuzelin, C
    Charroing, C
    Watier, H
    BLOOD, 2004, 104 (09) : 2791 - 2793
  • [48] Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT)
    Rauova, L.
    Arepally, G.
    McKenzie, S. E.
    Konkle, B. A.
    Cines, D. B.
    Poncz, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 249 - 252
  • [49] PLATELET FACTOR-IV COMPLEXED TO HEPARIN IS THE TARGET FOR ANTIBODIES GENERATED IN HEPARIN-INDUCED THROMBOCYTOPENIA
    AMIRAL, J
    BRIDEY, F
    DREYFUS, M
    VISSAC, AM
    FRESSINAUD, E
    WOLF, M
    MEYER, D
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (01) : 95 - 96
  • [50] Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia
    Sachais, Bruce S.
    Rux, Ann H.
    Cines, Douglas B.
    Yarovoi, Serge V.
    Garner, Lee I.
    Watson, Stephen P.
    Hinds, Jillian L.
    Rux, John J.
    BLOOD, 2012, 119 (25) : 5955 - 5962
12345